Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Catalyst Pharm Inc (NQ: CPRX ) 17.00 +0.06 (+0.35%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 671,383 Open 16.96 Bid (Size) 16.60 (14) Ask (Size) 17.20 (7) Prev. Close 16.94 Today's Range 16.74 - 17.07 52wk Range 11.55 - 17.50 Shares Outstanding 102,780,151 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024 Today 8:03 EDT The Company will Host a Conference Call and Webcast on Thursday, August 8, 2024, at 8:30 AM ET From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... Via Talk Markets Performance YTD -0.64% -0.64% 1 Month +9.04% +9.04% 3 Month +12.58% +12.58% 6 Month +12.21% +12.21% 1 Year +25.55% +25.55% More News Read More A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals June 03, 2024 Via Benzinga Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE® May 30, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Decoding 8 Analyst Evaluations For Catalyst Pharmaceuticals May 10, 2024 Via Benzinga Decoding 7 Analyst Evaluations For Catalyst Pharmaceuticals March 27, 2024 Via Benzinga Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024 May 28, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire 2 Incredible Growth Stocks to Buy Hand Over Fist Right Now May 15, 2024 Via The Motley Fool Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating May 14, 2024 Via Investor's Business Daily Catalyst's New CEO Has Big Ideas For The Small Biotech May 10, 2024 Via Investor's Business Daily CPRX Stock Earnings: Catalyst Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Assessing Catalyst Pharmaceuticals: Insights From 4 Financial Analysts March 07, 2024 Via Benzinga Top 10% Biotech Catalyst Pharma Slips On Mixed First-Quarter May 08, 2024 Via Investor's Business Daily Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update May 08, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024 May 01, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024 April 22, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day March 28, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium March 27, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire 3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List March 27, 2024 Via InvestorPlace 7 Biotech Stocks Ready to Ride the Sector’s Resurgence March 18, 2024 Via InvestorPlace Madrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating Benchmark March 18, 2024 Via Investor's Business Daily Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD) March 13, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire 3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio March 10, 2024 Via InvestorPlace Amicus Therapeutics Stock Sees RS Rating Improve To 74 March 05, 2024 Via Investor's Business Daily 3 Biopharma Stocks You Don't Want to Miss in the New Bull Market March 05, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.